Washington, D.C., Mar. 4, 2022 — Today, 72 organizations asked the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) to permanently waive the requirement that patients receive an in-person evaluation prior to being prescribed controlled substances via telemedicine. The organizations, convened by the American Psychiatric Association, the American Telemedicine Association, and ATA Action submitted the letter to the DEA as it is currently developing the Special Registration process for the use of telemedicine to prescribe controlled substances under the Ryan Haight Act.
During the COVID-19 public health emergency, the DEA used its authority to waive this...
Read More